cGxP.wire https://validator.w3.org/feed/docs/rss2.html Oncolys BioPharma Secures Japan Approval for Telomelysin in Esophageal Cancer FDA Approves New Sunscreen Ingredient After Two Decades Takeda’s ENTYVIO Nears Pediatric IBD FDA Approval Philips Finds AI Boosting Patient Access and Clinical Efficiency Worldwide HERVolution Advances Immune Therapy for Metabolic Disease Smith+Nephew Launches Next-Generation CORI XT Robotics Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Eti-cel Data at EHA 2026 Matter Bio Wins FDA IND Clearance for LM-LLO-TT Trial Anocca Doses First Patients with KRAS-Targeted TCR-T Therapy Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics SpinaFX Wins FDA IDE for Triojection Lumbar Disc Therapy Sonex Health Reports Largest U.S. Study Supporting UltraGuideCTR for Carpal Tunnel Subtle Medical Secures FDA Clearance for AI-Powered SubtleHD CT Nasus Pharma Reports Positive Preclinical Results for NS003 Curium Completes Phase 2 Dosing for 64Cu-PSMA-I&T in Japan Novartis Del-Brax Shows Breakthrough Potential in FSHD Novartis and Orionis Expand AI-Powered Molecular Glue Alliance Imviva Biotech Advances CTA313 CAR-T Program with FDA IND Approval Teva Acquires Emalex to Advance Tourette Syndrome Therapy Antengene Secures China IND Clearance for ATG-201 BioInvent’s TNFR2 Antibody BI-1808 Shows Promising Responses in Advanced CTCL at EHA 2026 Harbour BioMed Clears Regulatory Milestone for HBM7004 Disc Medicine Shares FDA Meeting Outcomes for Bitopertin Matica Biotechnology Partners with UHN on IL-10 Gene Therapy Manufacturing Lilly’s EBGLYSS Wins FDA Approval for Reduced Injection Schedule Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor Kyowa Kirin Highlights Vision 2030 in Integrated Report Syntax Bio Teams Up with Mayo Clinic to Advance Diabetes Treatment Onkos Surgical Receives FDA Nod for NanoCept-Enhanced Implants Alpha Cognition Reports Positive BEACON Study Results for ZUNVEYL Zetagen Therapeutics Reports Positive Phase 2a ZetaMet Results Multi Radiance Medical Expands FDA-Cleared Laser Therapy Indications Cellectis Secures FDA RMAT Status for Lasme-cel Sanofi Ends Phase 3 MOBILIZE Trial of Riliprubart in CIDP CONNECTA Therapeutics Initiates Phase IIa Study of CTH120 Argo Biopharma Reports Positive Phase 2 HAE Data for BW-20805 Eli Lilly and Shaquille O’Neal Raise Awareness of Treatable Sleep Apnea with Zepbound Kelun-Biotech and Windward Bio Advance SKB378 in COPD AlzeCure and Eli Lilly Partner on Alzheimer’s Drug ACD680 Vertanical’s Exilby Wins First European Approval for Chronic Pain RedHill’s Opaganib Gains FDA Rare Pediatric Disease Status Bial Discontinues Pariceract After Phase 2b ACTIVATE Trial Miss Vara Secures CE Mark for 3D Mammography AI Platform Pentixapharm Advances PANDA Phase 3 Study After FDA Clearance PureTech and Seaport Report Positive GlyphAgo Phase 1 Data Novanta Acquires Riverpoint Medical in $1.45 Billion Deal UCB Receives Favorable Canadian Reimbursement Opinion for BIMZELX Zai Lab Secures China Approval for TIVDAK in Cervical Cancer Pfizer’s HYMPAVZI Gains FDA Approval for Expanded Hemophilia Care Evaxion Presents New Preclinical Data for EVX-04 in Acute Myeloid Leukemia